All In Biotech

Free tool

FAERS Monitor: Twyneo

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214902 or its brand name (Twyneo, Benzoyl Peroxide, Tretinoin). Reports on generic versions are filed under their own applications.

Reports

38

Serious

2

5% of reports

Hospitalization

0

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • skin burning sensation7
  • acne6
  • erythema6
  • dry skin5
  • inappropriate schedule of product administration5
  • intentional product misuse4
  • pain of skin4
  • poor quality product administered4
  • pruritus4
  • drug ineffective3
  • product colour issue3
  • underdose3
  • dermatitis2
  • dry eye2
  • intentional underdose2

Reports by year received

View as table
YearReports
202210
202313
202410
20255

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,121 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product colour issueSignal3323.7109.2669
poor quality product administeredSignal4210.183.1637
intentional underdose2151.639.3168
pain of skinSignal482.232.5245
skin burning sensationSignal754.127.7315
dermatitis252.813.757
acneSignal643.821.0211
intentional product misuseSignal425.310.071
underdoseSignal322.77.743
dry eye222.25.822
dry skinSignal520.79.276
erythemaSignal616.27.872
inappropriate schedule of product administrationSignal515.46.854
pruritusSignal45.82.312
drug ineffective31.30.40

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.